Pulmonary Fibrosis_Interstitial Lung Disease

Gene: SFTPA1

Green List (high evidence)

SFTPA1 (surfactant protein A1)
EnsemblGeneIds (GRCh38): ENSG00000122852
EnsemblGeneIds (GRCh37): ENSG00000122852
OMIM: 178630, Gene2Phenotype
SFTPA1 is in 3 panels

2 reviews

Tiong Tan (Victorian Clinical Genetics Services)

Green List (high evidence)

3 additional families reported with monoallelic variants in SFTPA1 - sufficient to warrant Green classification?
Created: 2 Nov 2022, 1:23 a.m. | Last Modified: 2 Nov 2022, 1:23 a.m.
Panel Version: 0.45

Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Four families and a mouse model, bi-allelic disease appears to be more severe, earlier onset.
Sources: Literature
Created: 6 Jul 2020, 8:51 a.m.

Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal

Phenotypes
Idiopathic pulmonary fibrosis; Interstitial lung disease 1, MIM# 619611

Publications

Details

Mode of Inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Literature
Phenotypes
  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease 1, MIM# 619611
OMIM
178630
Clinvar variants
Variants in SFTPA1
Penetrance
None
Publications
Panels with this gene

History Filter Activity

2 Nov 2022, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: SFTPA1 were set to 31601679; 30854216; 28869238; 26792177

2 Nov 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: sftpa1 has been classified as Green List (High Evidence).

25 Nov 2021, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: SFTPA1 were changed from Idiopathic pulmonary fibrosis to Idiopathic pulmonary fibrosis; Interstitial lung disease 1, MIM# 619611

6 Jul 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: sftpa1 has been classified as Amber List (Moderate Evidence).

6 Jul 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: sftpa1 has been classified as Amber List (Moderate Evidence).

6 Jul 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: SFTPA1 was added gene: SFTPA1 was added to Pulmonary Fibrosis_Interstitial Lung Disease. Sources: Literature Mode of inheritance for gene: SFTPA1 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal Publications for gene: SFTPA1 were set to 31601679; 30854216; 28869238; 26792177 Phenotypes for gene: SFTPA1 were set to Idiopathic pulmonary fibrosis Review for gene: SFTPA1 was set to AMBER